RedHill Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	23.92	-71.67	-97.74	-76.17	-42.3	-38.82	-45.54	-29.37	-21.09	-10.71	Upgrade
Depreciation & Amortization	1.99	8.15	18.15	8.75	1.21	0.09	0.08	0.04	0.04	0.03	Upgrade
Share-Based Compensation	1.65	5.68	10.21	4.2	3.03	2.68	2.24	1.68	1.36	1.75	Upgrade
Other Operating Activities	-63.37	28.66	4.34	14.65	-2.69	1.59	-1.54	-0.61	1.86	-3.3	Upgrade
Operating Cash Flow	-35.82	-29.19	-65.05	-48.58	-40.75	-34.46	-44.77	-28.26	-17.83	-12.23	Upgrade
Capital Expenditures	-0.01	-0.2	-0.12	-0.41	-0.17	-0.02	-0.15	-0.09	-0.01	-0.07	Upgrade
Change in Investments	0.02	8.5	-8.03	18.13	5.37	5.41	-17.4	24.59	-19.56	-16.76	Upgrade
Other Investing Activities	-	-	-	-53.37	-0.04	-0.04	-1.04	-0.04	-1.62	-1.04	Upgrade
Investing Cash Flow	0	8.3	-8.14	-35.65	5.16	5.35	-18.58	24.47	-21.19	-17.86	Upgrade
Share Issuance / Repurchase	13.96	23.81	78.54	23.87	36.3	41.9	22.22	35.75	54.68	19.36	Upgrade
Debt Issued / Paid	-1.18	-1.48	-1.68	76.45	-0.8	0	0	0	0	0	Upgrade
Other Financing Activities	8.66	-10.88	-3.39	-15.95	0.01	-0.14	3.44	0.26	0.11	5.01	Upgrade
Financing Cash Flow	21.44	11.45	73.46	84.37	35.51	41.76	25.65	36.02	54.79	24.37	Upgrade
Exchange Rate Effect	-0.02	-0.08	-0.1	0.13	0.09	-0.1	0.37	0.04	-0.15	-0.24	Upgrade
Net Cash Flow	-14.38	-9.43	0.28	0.14	-0.08	12.65	-37.7	32.23	15.77	-5.72	Upgrade
Free Cash Flow	-35.83	-29.38	-65.16	-48.99	-40.92	-34.49	-44.92	-28.34	-17.84	-12.3	Upgrade
Free Cash Flow Margin	-548.71%	-47.55%	-75.98%	-76.11%	-650.41%	-412.50%	-1120.91%	-28062.38%	-594666.67%	-175.35%	Upgrade
Free Cash Flow Per Share	-11.21	-18.41	-55.70	-55.55	-57.69	-64.84	-105.32	-89.19	-81.20	-56.80	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).